Mycobacteria lacking the RD1 region do not induce necrosis in the lungs of mice lacking interferon-gamma.
The genetic region of difference 1 (RD1) in Mycobacterium tuberculosis has recently been hypothesized to encode for proteins that are cytotoxic to the host cell in nature. We demonstrate here that while M. tuberculosis grew progressively in the lungs of gene disrupted mice (GKO) unable to produce interferon-gamma (IFN-gamma), similar mice infected instead with M. bovis bacillus Calmette-Guérin (BCG) reproducibly exhibited an obvious slowing of the disease after about 20 days. Closer examination of BCG-infected GKO mice showed a florid granulomatous inflammation in the lungs, whereas similar mice infected with M. tuberculosis exhibited wholesale progressive necrosis. In the BCG-infected GKO mice large numbers of activated effector T cells, some strongly positive for the cytokine tumour necrosis factor, as well as activated natural killer cells accumulated in the lungs. To further test the hypothesis that the differences observed were directly associated with the loss of the RD1 region, it was then shown that a mutant of M. tuberculosis lacking RD1 grew progressively in both normal and GKO mice but failed to induce any degree of necrosis in either animal despite reaching similar levels in the lungs. However, when mice were infected with this mutant, in which the RD1 region had been restored by complementation, wholesale necrosis of the lungs again occurred. These data support the hypothesis that proteins encoded in the RD1 region are a major cause of necrosis and contribute significantly to the pathogenesis of the disease.
Junqueira-Kipnis
Ana Paula
AP
Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Basaraba
Randall J
RJ
Gruppo
Veronica
V
Palanisamy
Gopinath
G
Turner
Oliver C
OC
Hsu
Tsungda
T
Jacobs
William R
WR
Fulton
Scott A
SA
Reba
Scott M
SM
Boom
W Henry
WH
Orme
Ian M
IM
D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D002465:Cell Movement / Q000276:immunology; D018450:Disease Progression; D005260:Female; D005798:Genes, Bacterial; D007371:Interferon-gamma / Q000172:deficiency / Q000235:genetics / Q000276:immunology*; D008168:Lung / Q000382:microbiology / Q000473:pathology*; D008213:Lymphocyte Activation / Q000276:immunology; D008262:Macrophage Activation / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009163:Mycobacterium bovis / Q000235:genetics / Q000254:growth & development / Q000472:pathogenicity*; D009169:Mycobacterium tuberculosis / Q000235:genetics / Q000254:growth & development / Q000472:pathogenicity*; D009336:Necrosis; D014376:Tuberculosis / Q000276:immunology* / Q000382:microbiology; D014774:Virulence
D001426:Bacterial Proteins; D007371:Interferon-gamma